MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

MIS416

MIS416 Multiple Sclerosis Trial Results

MStranslate
June 28, 2017
MIS416, Research, Treatments
On Tuesday, Innate Immunotherapeutics released a report outlining the first set of results from their Phase 2b trial on the use of their compound, MIS416, in people with secondary progressive multiple...

Warwick: From Medieval Times to MStranslate

MStranslate
June 21, 2017
Community, MStranslate
Warwick, England.  Famously known as the home of Warwick Castle, an amazing castle built by William the Conqueror in 1068.  The town is situated on the River Avon and is one of those places that just exudes...
AHSCT

Multiple Sclerosis Treatment Overview: AHSCT

MStranslate
June 13, 2017
Stem Cells, Treatments
1 Comment
Recently, I’ve had the pleasure of talking to a number of different local multiple sclerosis support groups about multiple sclerosis (MS) and MS research.  These events generally involve me giving a small...
genetics

Genetics & MS: Can It Be Inherited?

MStranslate
June 6, 2017
Uncategorized
Recently, I’ve had the pleasure of talking to a number of different local multiple sclerosis support groups about multiple sclerosis (MS) and MS research.  These events generally involve me giving a small...
interferon-beta

Health Impacts of Interferon-beta Use in MS

MStranslate
May 16, 2017
Interferon-beta, Research, Treatments
Research Summary: Evaluating the safety of β-interferons in MS Research from the University of British Columbia has looked at the long-term health effects of interferon-beta treatment in people with...
statins

Secondary Progressive Multiple Sclerosis & Statins

MStranslate
May 15, 2017
Research, Treatments
There has been a lot of media attention recently on a trial testing statins as a treatment for multiple sclerosis (MS).  The study is being led by University College London and will involve over 1100 people...
Laquinimod

Multiple Sclerosis Clinical Trial Update: Laquinimod

MStranslate
May 9, 2017
Clinical Trials, Laquinimod, Research
What is laquinimod? Laquinimod is a once-daily oral medication that has been developed and tested for the treatment of relapsing-remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS). The...
Daclizumab

Multiple Sclerosis Treatment Information: Daclizumab

MStranslate
May 3, 2017
Daclizumab, Treatments
It has been reported this week that daclizumab (marketed as Zinbryta) has been added to the Pharmaceutical Benefits Scheme (PBS) in Australia.  Considering this, we thought it appropriate to provide some more...
BMI

BMI & Lipid Levels Impact MS Progression

MStranslate
April 26, 2017
Diet, Lifestyle, Research
2 Comments
Research Summary: An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event An increasing emphasis is being placed on how lifestyle...

Multiple Sclerosis: One Disease, Many Causes?

MStranslate
April 18, 2017
Research, Understanding Science
1 Comment
In one of our recent Facebook Live Q&A sessions, I was asked what I thought the biggest hurdle was that needed to be overcome in multiple sclerosis research.  Whilst funding problems are something that we...
  1. 14
  2. 15
  3. 16
  4. 17
  5. 18
  6. 19
  7. 20

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.